Definition
A compounding pharmacy is a licensed pharmacy that prepares customized medications tailored to individual patient needs. Unlike conventional pharmacies that dispense commercially manufactured drugs in standardized forms and doses, compounding pharmacies create medications from raw pharmaceutical ingredients according to a prescriber's specific instructions. In the context of ketamine therapy, compounding pharmacies are the primary source of oral tablets, sublingual troches, rapid-dissolve tablets, nasal sprays, and topical creams — formulations that are not available as commercially manufactured products.
How Compounding Works
Compounding pharmacists combine active pharmaceutical ingredients (APIs) with excipients — inactive ingredients such as binders, flavorings, and preservatives — to create a finished medication in the form, dose, and delivery method specified by the prescribing clinician. For more on what patients should know about compounded medications, see our compounding pharmacy guide. For ketamine, this process typically involves:
- Sourcing pharmaceutical-grade racemic ketamine powder from FDA-registered suppliers
- Precisely measuring the prescribed dose using calibrated analytical balances
- Combining the ketamine with appropriate excipients for the desired dosage form
- Performing quality checks to verify potency, uniformity, and sterility (when applicable)
- Packaging and labeling the finished product with complete prescription information
Common compounded ketamine formulations include sublingual troches (lozenges designed to dissolve under the tongue), rapid-dissolve tablets, oral solutions, nasal spray preparations, and topical creams for pain management.
Regulatory Framework
Compounding pharmacies operate under a distinct regulatory framework from commercial drug manufacturers. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications in response to individual prescriptions. Section 503B governs outsourcing facilities — larger-scale operations that may compound drugs in anticipation of prescriptions without patient-specific orders.
Key regulatory requirements include:
- State licensing: Every compounding pharmacy must hold a valid state pharmacy license and comply with state board of pharmacy regulations, which vary by jurisdiction.
- USP standards: Compounded preparations must meet United States Pharmacopeia (USP) standards for quality, including USP <795> for non-sterile compounding and USP <797> for sterile preparations.
- Prescription requirement: Under Section 503A, compounded medications may only be prepared in response to a valid patient-specific prescription from a licensed prescriber.
- DEA compliance: Because ketamine is a Schedule III controlled substance, compounding pharmacies must hold a DEA registration, maintain detailed dispensing records, and comply with all applicable controlled substance regulations.
Role in Ketamine Treatment
Compounding pharmacies are indispensable to the current ketamine treatment landscape for several reasons:
Formulation flexibility: The only FDA-approved ketamine-based product for depression is the esketamine nasal spray. All other ketamine formulations used for psychiatric treatment — including the widely prescribed sublingual troches used in at-home programs — are compounded. Without compounding pharmacies, these treatment options would not exist.
Dose customization: Clinicians can prescribe exact doses tailored to each patient's weight, tolerance, and clinical response. This is particularly valuable for ketamine, where optimal dosing varies significantly between individuals and may require fine-tuned adjustments over the course of treatment.
Cost accessibility: Compounded ketamine formulations are typically far less expensive than the branded esketamine product, which can cost over $500 per treatment session before insurance. Compounded troches or tablets may cost a fraction of that amount, making ketamine therapy financially accessible to a broader patient population.
Route of administration options: Not all patients can tolerate or access IV infusion clinics. Compounded oral and sublingual formulations enable at-home treatment under clinical supervision, significantly expanding access to ketamine therapy.
Quality Considerations
Because compounded medications are not subject to the same FDA approval process as commercially manufactured drugs, quality assurance depends heavily on the individual pharmacy's practices, equipment, and oversight. Patients and providers should consider:
- Whether the pharmacy holds accreditation from organizations such as the Pharmacy Compounding Accreditation Board (PCAB)
- The pharmacy's track record with state board of pharmacy inspections
- Whether the pharmacy conducts third-party potency and purity testing on its compounded products
- The pharmacy's compliance with current USP compounding standards
References
- FDA Information on Drug Compounding — Official FDA resource on compounding regulations and safety.
- USP Compounding Standards — United States Pharmacopeia compounding quality standards.
- Section 503A and 503B of the FD&C Act — Federal statutory framework for compounding pharmacies.
- NABP Compounding Resources — National Association of Boards of Pharmacy compounding oversight information.
Share